JP Morgan Chase
PRAX icon

JP Morgan Chase’s Praxis Precision Medicines PRAX Stock Holding History

JP Morgan Chase’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Sell
44,085
-36,095
-45% -$11.4M ﹤0.01% 2411
2026
Q1 		$22.2M Buy
80,180
+24,880
+45% +$7.7M ﹤0.01% 1983
2025
Q4 		$16.3M Buy
55,300
+29,092
+111% +$5.42M ﹤0.01% 2239
2025
Q3 		$1.39M Buy
26,208
+12,270
+88% +$595K ﹤0.01% 4349
2025
Q2 		$586K Buy
13,938
+2,459
+21% +$93.6K ﹤0.01% 4691
2025
Q1 		$435K Buy
11,479
+1,786
+18% +$112K ﹤0.01% 4866
2024
Q4 		$746K Buy
9,693
+1,879
+24% +$136K ﹤0.01% 4818
2024
Q3 		$450K Buy
7,814
+448
+6% +$24.2K ﹤0.01% 4964
2024
Q2 		$305K Sell
7,366
-44,006
-86% -$2.08M ﹤0.01% 4934
2024
Q1 		$3.13M Buy
51,372
+51,355
+302,088% +$2.3M ﹤0.01% 3480
2023
Q4 		$379 Sell
17
-81
-83% -$1.46K ﹤0.01% 6960
2023
Q3 		$2.5K Hold
98
– – ﹤0.01% 6506
2023
Q2 		$1.69K Sell
98
-2,435
-96% -$37.3K ﹤0.01% 6375
2023
Q1 		$31K Buy
2,533
+1,008
+66% +$42.5K ﹤0.01% 5861
2022
Q4 		$54K Sell
1,525
-51
-3% -$1.59K ﹤0.01% 5598
2022
Q3 		$53K Buy
1,576
+77
+5% +$3.84K ﹤0.01% 5530
2022
Q2 		$55K Sell
1,499
-754
-33% -$80.5K ﹤0.01% 5628
2022
Q1 		$345K Buy
2,253
+335
+17% +$68.8K ﹤0.01% 4912
2021
Q4 		$568K Buy
1,918
+383
+25% +$112K ﹤0.01% 4746
2021
Q3 		$425K Buy
1,535
+442
+40% +$120K ﹤0.01% 4824
2021
Q2 		$300K Buy
1,093
+596
+120% +$213K ﹤0.01% 5016
2021
Q1 		$244K Buy
497
+125
+34% +$88.9K ﹤0.01% 5068
2020
Q4 		$308K Buy
+372
New +$217K ﹤0.01% 4643

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

JP Morgan Chase's PRAX Position: Q2 2026 in Review

JP Morgan Chase reduced its Praxis Precision Medicines (PRAX) stake by 45% in Q2 2026, selling an estimated $11.4M and leaving 44,085 shares worth $15.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2411.

JP Morgan Chase first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. The position peaked at $22.2M in Q1 2026. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • JP Morgan Chase held 44,085 shares of Praxis Precision Medicines worth $15.8M as of Q2 2026.
  • JP Morgan Chase sold 36,095 Praxis Precision Medicines shares in Q2 2026, an estimated $11.4M.
  • Praxis Precision Medicines made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2411 holding.
  • JP Morgan Chase first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
  • JP Morgan Chase's Praxis Precision Medicines position peaked at $22.2M in Q1 2026.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.